Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (441-450 of 636) with videos related to

Pageof 64
Sort By:
Gut|December 31, 2025
Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunitiesXiao-Dong Zhou, Qiong-Yue Fan, Christopher D Byrne, et al.
Nature Communications|March 31, 2019
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver diseaseCyrielle Caussy, Anupriya Tripathi, Greg Humphrey, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 6, 2024
Effects of Food Insecurity on Hepatic Steatosis and Fibrosis in People With HIVAni Kardashian, Audrey Lloyd, Eduardo Vilar-Gomez, et al.
Alimentary Pharmacology & Therapeutics|December 20, 2021
Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortalityMayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
The New England Journal of Medicine|June 10, 2024
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver FibrosisRohit Loomba, Mark L Hartman, Eric J Lawitz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 24, 2021
Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational CohortMiguel H Malespin, Alfred Sidney Barritt, Stephanie E Watkins, et al.
Gastroenterology|April 17, 2018
Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseVeeral Ajmera, Charlie C Park, Cyrielle Caussy, et al.
Alimentary Pharmacology & Therapeutics|March 1, 2022
Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective studyDaniel Q Huang, Kathryn J Fowler, Joy Liau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2021
Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C VirusNobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, et al.
Hepatology (Baltimore, Md.)|September 1, 2017
Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver diseaseRaj Vuppalanchi, Mohammad S Siddiqui, Mark L Van Natta, et al.
Pageof 64

Showing results (441-450 of 636) with videos related to

Sort By:
Pageof 64
Gut|December 31, 2025
Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunitiesXiao-Dong Zhou, Qiong-Yue Fan, Christopher D Byrne, et al.
Nature Communications|March 31, 2019
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver diseaseCyrielle Caussy, Anupriya Tripathi, Greg Humphrey, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 6, 2024
Effects of Food Insecurity on Hepatic Steatosis and Fibrosis in People With HIVAni Kardashian, Audrey Lloyd, Eduardo Vilar-Gomez, et al.
Alimentary Pharmacology & Therapeutics|December 20, 2021
Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortalityMayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
The New England Journal of Medicine|June 10, 2024
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver FibrosisRohit Loomba, Mark L Hartman, Eric J Lawitz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 24, 2021
Weight Loss and Weight Regain in Usual Clinical Practice: Results From the TARGET-NASH Observational CohortMiguel H Malespin, Alfred Sidney Barritt, Stephanie E Watkins, et al.
Gastroenterology|April 17, 2018
Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseVeeral Ajmera, Charlie C Park, Cyrielle Caussy, et al.
Alimentary Pharmacology & Therapeutics|March 1, 2022
Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective studyDaniel Q Huang, Kathryn J Fowler, Joy Liau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2021
Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C VirusNobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, et al.
Hepatology (Baltimore, Md.)|September 1, 2017
Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver diseaseRaj Vuppalanchi, Mohammad S Siddiqui, Mark L Van Natta, et al.
Pageof 64